Skip to main content

Guillain-Barré-Syndrom und chronische entzündliche demyelinisierende Polyradikuloneuritis

  • Chapter
  • 72 Accesses

Zusammenfassung

Nach dem fast völligen Verschwinden der Poliomyelitis ist das Guillain-Bar-ré-Syndrom (GBS) die häufigste Ursache akuter peripherer Lähmungen in der westlichen Welt geworden. Die jährliche Inzidenz liegt zwischen 1 und 2 Fällen/100 000 Einwohner mit leichter Bevorzugung des männlichen Geschlechts. Initial wird häufig über periphere sensible Reizerscheinungen geklagt. Dann treten innerhalb kurzer Zeit motorische Ausfälle auf. Diese sind zunächst an den Extremitäten distal akzentuiert, können sich aber wegen der Mitbeteiligung der Spinalwurzeln auch rasch auf proximale Muskeln ausdehnen:

Rasch aufsteigende Lähmungen sind typisch.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Weiterführende Literatur

  • Buchwald B, Weishaupt A, Toyka KV, Dudel J (1998) Pre-and postsynaptic blockade of neu-romuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals. Eur J Neurosci 10:281–290.

    Article  CAS  PubMed  Google Scholar 

  • Buchwald B, Dudel J, Zielasek J, Weishaupt A, Schweiger S, Toyka KV (1998) Neuromuscu-lar blockade by IgG antibodies from patients with Guillain-Barré syndrome. Ann Neurol 44:913–922.

    Article  CAS  PubMed  Google Scholar 

  • Dutch Guillain-Barré Study Group (1994) Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. Ann Neurol 35:749–752.

    Article  Google Scholar 

  • Dyck PJ, Litchy WJ, Kratz KM et al. (1994) A plasma exchange vs. immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 36:838–845.

    Article  CAS  PubMed  Google Scholar 

  • Enders U, Karch H, Toyka KV et al. (1993) The spectrum of immune responses to campylo-bacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmu-nological disorders. Ann Neurol 34:136–144.

    Article  CAS  PubMed  Google Scholar 

  • Flachenecker P, Wermuth P, Hartung HP, Reiners K (1997) Quantitative assessment of cardiovascular autonomic function in Guillain-Barré syndrome. Ann Neurol 42:171–179.

    Article  CAS  PubMed  Google Scholar 

  • French Cooperative Group on Plasma Exchange in Guillain-Barré-Syndrome (1987) Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann Neurol 22:753–761.

    Article  Google Scholar 

  • French Cooperative Group on Plasma Exchange in Guillain-Barré-Syndrome (1997) Appropriate number of plasma exchanges in Guillain-Barré syndrome [see comments]. Ann Neurol 41:298–306.

    Article  Google Scholar 

  • Gold R, Härtung HP (1993) Therapie von Immunneuropathien. Akt Neurol 20:147–160.

    Article  Google Scholar 

  • Guillain-Barré-Syndrome Steroid Trial Group (1993) Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Lancet 341:586–590.

    Google Scholar 

  • Hadden RDM, Cornblath DR, Hughes RAC et al. (1998) Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 44:780–788.

    Article  CAS  PubMed  Google Scholar 

  • Härtung HP, Pollard JD, Harvey GK, Toyka KV (1995) Immunopathogenesis and treatment of the Guillain-Barré syndrome — part I and part II. Muscle Nerve 18:137–164.

    Article  PubMed  Google Scholar 

  • Ho TW, Hsieh ST, Nachamkin I et al. (1997) Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection [see comments]. Neurology 48:717–724.

    Article  CAS  PubMed  Google Scholar 

  • Hughes RAC (1990) Guillain-Barré syndrome. Springer, London Berlin Heidelberg.

    Book  Google Scholar 

  • Hughes RAC, Swan AV, Cornblath DR et al. (1997) Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 349:225–230.

    Article  Google Scholar 

  • Jacobs BC, Endtz H, van der Meché FGA et al. (1995) Serum anti-GQ1b IgG antibodies recognize surface epitopes on campylobacter jejuni from patients with Miller Fisher syndrome. Ann Neurol 37:260–264.

    Article  CAS  PubMed  Google Scholar 

  • Kiefer R, Kieseier BC, Brück W, Härtung H-P, Toyka KV (1998) Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain 121:469–479.

    Article  PubMed  Google Scholar 

  • Li CY, Xue P, Tian WQ, Liu RC, Yang C (1996) Experimental campylobacter jejuni infection in the chicken: An animal model of axonal Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 61:279–284.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ropper AH (1992) The Guillain-Barré syndrome. N Engl J Med 326:1130–1136.

    Article  CAS  PubMed  Google Scholar 

  • Schmidt B, Toyka KV, Kiefer R, Full J, Härtung HP, Pollard J (1996) Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 19:474–487.

    Article  CAS  PubMed  Google Scholar 

  • Stängel M, Härtung HP, Marx P, Gold R (1997) Side effects of high-dose intravenous immu-noglobulins. Clin Neuropharmacol 20:385–393.

    Article  PubMed  Google Scholar 

  • Stängel M, Toyka KV, Gold R (1998) Mechanisms of high dose intravenous immunoglobu-lins in demyelinating diseases. Arch Neurol (in press).

    Google Scholar 

  • Toyka KV, Härtung HP (1996) Chronic inflammatory polyneuritis and related neuropathies. Curr Opin Neurol 9:240–250.

    Article  CAS  PubMed  Google Scholar 

  • Van der Meche FGA, Schmitz PIM, and the Dutch Guillain-Barré Study Group (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 326:1123–1129.

    Article  PubMed  Google Scholar 

  • Weiß H, Ravtan V, Müllges W, Toyka KV (1999) Psychotic symptoms and emotional distress in patients suffering from acute Guillain-Barré syndrome (in Vorbereitung).

    Google Scholar 

  • Winer JB, Hughes RAC, Osmond C (1988) A prospective study of acute idiopathic neuropathy. I: Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 51:605–612.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M, Saito K et al. (1993) A bacterium lipopo-lysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 178:1771–1775.

    Article  CAS  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gold, R., Müllges, W., Toyka, K.V. (1999). Guillain-Barré-Syndrom und chronische entzündliche demyelinisierende Polyradikuloneuritis. In: Schwab, S., Krieger, D., Müllges, W., Hamann, G., Hacke, W. (eds) Neurologische Intensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58415-2_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-58415-2_35

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63583-0

  • Online ISBN: 978-3-642-58415-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics